CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 2 Platform Trial to Assess the Efficacy and Safety of Long-acting Antibodies as Single Agents and in Combinations for Moderately to Severely Active Ulcerative Colitis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07012395
Title field or adapter rule: {'original_value': 'Phase 2 Platform Trial to Assess the Efficacy and Safety of Long-acting Antibodies as Single Agents and in Combinations for Moderately to Severely Active Ulcerative Colitis', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:36.182817+00:00
Published At: 2026-10-27T00:00:00+00:00
Record Updated At: 2026-10-27
Source Retrieved At: 2026-10-31T22:18:58.295941+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

protocolSection.conditionsModule.conditions: ["Ulcerative Colitis", "Inflammatory Bowel Diseases", "Colitis", "Colitis, Ulcerative"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-27", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT07012395"
protocolSection.identificationModule.officialTitle: "Phase 2 Platform Trial to Assess the Efficacy and Safety of Long-acting Antibodies as Single Agents and in Combinations for Moderately to Severely Active Ulcerative Colitis"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct: null

{'armGroupLabels': ['Intervention Specific Appendix - SPY001 Dosing Regimen 1: Part B', 'Intervention Specific Appendix - SPY001 Dosing Regimen 2: Part B', 'Intervention Specific Appendix - SPY001: Part A', 'Intervention Specific Appendix - SPY120: Part B', 'Intervention Specific Appendix - SPY130: Part B'], 'description': 'Experimental', 'name': 'SPY001', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Intervention Specific Appendix - SPY002 Dosing Regimen 1: Part B', 'Intervention Specific Appendix - SPY002 Dosing Regimen 2: Part B', 'Intervention Specific Appendix - SPY002: Part A', 'Intervention Specific Appendix - SPY120: Part B', 'Intervention Specific Appendix - SPY230: Part B'], 'description': 'Experimental', 'name': 'SPY002', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Intervention Specific Appendix - SPY003 Dosing Regimen 1: Part B', 'Intervention Specific Appendix - SPY003 Dosing Regimen 2: Part B', 'Intervention Specific Appendix - SPY003: Part A', 'Intervention Specific Appendix - SPY130: Part B', 'Intervention Specific Appendix - SPY230: Part B'], 'description': 'Experimental', 'name': 'SPY003', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Placebo: Part B'], 'description': 'Placebo', 'name': 'Placebo', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.